About
Amy Stiegler is a Research Scientist in Pharmacology at Yale School of Medicine, Yale University. She holds a PhD from New York University and a BS from Georgetown University. Her research focuses on structural biology, protein interactions, and genetic mechanisms underlying diseases such as agammaglobulinemia and craniosynostosis. She collaborates extensively with Titus Boggon and others on projects involving protein domains (e.g., SH2, SH3) and their roles in signal transduction. Recent work includes studies on ERK2 specificity mutations and PU.1 haploinsufficiency. Her publications span structural biochemistry, genetic disorders, and oncology, with a focus on translating structural insights into disease mechanisms.
- Education: PhD (NYU, 2007), BS (Georgetown, 2001)
- Key Research Areas: Protein structure-function relationships, genetic mutations in diseases, cell signaling pathways
Her work bridges molecular pharmacology and clinical genetics, contributing to drug target identification and understanding congenital disorders. No awards or grants explicitly listed, but her collaborative projects suggest active research funding.
